Prior studies of the genetics of cylindrocarcinoma are limited; investigations have to-date described TP53 mutations in small numbers of cylindrocarcinomas within larger series of adnexal carcinomas [42, 43]. This evidence concerns the gene TP53 and skin appendage carcinoma.